A patient taking a selective serotonin reuptake inhibitor (SSRI) may be at increased risk for gastric bleeding. Paton and Ferrier identified situations when gastroprotective therapy may be indicated in a patient taking an SSRI. The authors are from the Oxleas NHS Trust and the University of Newcastle Upon Tyne in England.
